{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:31:36Z","timestamp":1787502696295,"version":"build-2736575974"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"\n Introduction<\/jats:title>\n \n oncocytic thyroid adenoma (OA), a rare benign neoplasm, poses diagnostic challenges in conventional imaging modalities. The study investigates the diagnostic utility of dual-tracer\n 18<\/jats:sup>\n F-fluorodeoxyglucose (\n 18<\/jats:sup>\n F-FDG) and\n 18<\/jats:sup>\n F-AlF-NOTA-octreotide (\n 18<\/jats:sup>\n F-OC) positron emission tomography\/computed tomography (PET\/CT) in characterizing OA.\n <\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n We present a histopathologically confirmed OA case evaluated through simultaneous\n 18<\/jats:sup>\n F-FDG and\n 18<\/jats:sup>\n F-OC PET\/CT imaging. Quantitative analysis included maximum standardized uptake value (SUVmax), mean standardized uptake value (SUVmean), and metabolic tumor volume (MTV). A systematic literature review was conducted to contextualize the imaging findings within existing evidence.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n A 44-year-old female presenting with ACTH-independent Cushing syndrome (morning cortisol 632.8 nmol\/L, non-suppressed on dexamethasone suppression tests) underwent comprehensive endocrine evaluation. Incidentally detected thyroid nodule demonstrated discordant tracer uptake:\n 18<\/jats:sup>\n F-FDG PET\/CT revealed intense hypermetabolism (SUVmax=31.68; SUVmean=9.18; MTV=4.33 cm\n 3<\/jats:sup>\n ), while\n 18<\/jats:sup>\n F-OC PET\/CT showed moderate uptake (SUVmax=6.86; SUVmean=4.41; MTV=1.72 cm\n 3<\/jats:sup>\n ). Histopathology confirmed OA with negative SSTR2 expression. Postoperative cortisol levels remained elevated. After nearly two years of clinical follow-up with conservative management using symptomatic medication, she underwent pituitary lesion resection, which confirmed a pituitary adenoma\/pituitary neuroendocrine tumor (PitNET) consistent with a densely granulated corticotroph tumor.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n This case demonstrates the complementary diagnostic value of dual-tracer PET\/CT in OA characterization, particularly in SSTR2-negative variants. The discordant uptake patterns suggest distinct metabolic pathways in OA pathophysiology. Prospective multicenter studies with larger cohorts are warranted to establish standardized diagnostic criteria and explore theranostic applications of these imaging biomarkers in OA.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fendo.2025.1612851","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T04:11:04Z","timestamp":1756440664000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Dual-tracer 18F-FDG and 18F-AlF-NOTA-octreotide PET\/CT imaging in oncocytic thyroid adenoma: a case report and literature review"],"prefix":"10.3389","volume":"16","author":[{"given":"Jing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"key":"B1","volume-title":"WHO Classification of Tumours: Endocrine and Neuroendocrine Tumours","author":"Asa","year":"2022"},{"key":"B2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","article-title":"Overview of the 2022 WHO classification of thyroid neoplasms","volume":"33","author":"Baloch","year":"2022","journal-title":"Endocr Pathol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.19723\/j.issn.1671-167X.2020.06.018","article-title":"Analysis of diagnosis and treatment of 100 patients with H\u00fcrthle cell adenoma [\u7532\u72b6\u817a\u55dc\u9178\u7ec6\u80de\u817a\u7624100\u4f8b\u8bca\u6cbb\u5206\u6790","volume":"52","author":"Kang","year":"2020","journal-title":"Beijing Da Xue Xue Bao Yi Xue Ban"},{"key":"B4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4274\/mirt.9469","article-title":"Thyroid incidentalomas on 18F-FDG PET\/CT: clinical significance and controversies","volume":"26","author":"Makis","year":"2017","journal-title":"Mol Imaging Radionucl Ther"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000002578","article-title":"Clinical application of 18F-AlF-NOTA-Octreotide PET\/CT in combination with 18F-FDG PET\/CT for imaging neuroendocrine neoplasms","volume":"44","author":"Long","year":"2019","journal-title":"Clin Nucl Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF01662011","article-title":"Beitr\u00e4ge zur Kenntniss der Secretionsvorg\u00e4nge in der Schilddr\u00fcse [On the knowledge of secretory processes in the thyroid gland","volume":"56","author":"H\u00fcrthle","year":"1894","journal-title":"Arch Ges Physiol"},{"key":"B7","volume-title":"WHO Classification of Tumours of Endocrine Organs","author":"Lloyd","year":"2017"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/BF03215865","article-title":"H\u00fcrthle cell tumor of the thyroid: analysis of 188 cases","volume":"25","author":"Sugino","year":"2001","journal-title":"World J Surg"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2005.11.023","article-title":"Surgery for thyroid H\u00fcrthle cell tumours\u2013a single institution experience","volume":"32","author":"Paunovic","year":"2006","journal-title":"Eur J Surg Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.7150\/jca.1.23","article-title":"Age and tumor size predicts lymph node involvement in H\u00fcrthle Cell Carcinoma","volume":"1","author":"Guerrero","year":"2010","journal-title":"J Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/jso.21526","article-title":"Predictive factors of carcinoma in 279 patients with H\u00fcrthle cell neoplasm of the thyroid gland","volume":"101","author":"Strazisar","year":"2010","journal-title":"J Surg Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0628","article-title":"American thyroid association guidelines on the management of thyroid nodules and differentiated thyroid cancer task force review and recommendation on the proposed renaming of encapsulated follicular variant papillary thyroid carcinoma without invasion to noninvasive follicular thyroid neoplasm with papillary-like nuclear features","volume":"27","author":"Haugen","year":"2017","journal-title":"Thyroid"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31245","article-title":"Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules","volume":"124","author":"Nikiforova","year":"2018","journal-title":"Cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.22101","article-title":"The prevalence and surgical outcomes of H\u00fcrthle cell lesions in FNAs of the thyroid: A multi-institutional study in 6 Asian countries","volume":"127","author":"Agarwal","year":"2019","journal-title":"Cancer Cytopathol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"130051","DOI":"10.1530\/EDM-13-0051","article-title":"Late bone metastasis from an apparently benign oncocytic follicular thyroid tumor","volume":"2013","author":"Boronat","year":"2013","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-23-0047","article-title":"A clinically applicable molecular classification of oncocytic cell thyroid nodules","volume":"30","author":"de Koster","year":"2023","journal-title":"Endocr Relat Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/jcu.20684","article-title":"H\u00fcrthle cell neoplasm: correlation of gray-scale and power Doppler sonographic findings with gross pathology","volume":"38","author":"Lee","year":"2010","journal-title":"J Clin Ultrasound"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000015866","article-title":"Typical manifestations of H\u00fcrthle cell adenoma of the thyroid on contrast-enhanced CT: A case report","volume":"98","author":"Deng","year":"2019","journal-title":"Med (Baltimore)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-021-05627-2","article-title":"18F]FDG-PET\/CT to prevent futile surgery in indeterminate thyroid nodules: a blinded, randomised controlled multicentre trial","volume":"49","author":"de Koster","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1967\/s002449912550","article-title":"Indeterminate thyroid cytology in an iodine-deficient population: Prevalence, operation rate, risk of Malignancy anddiagnostic value of thyroid scintigraphy and 18F-FDG PET imaging parameters","volume":"26","author":"Almasi","year":"2023","journal-title":"Hell J Nucl Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6511179","article-title":"The potential prognostic value of dual-imaging PET parameters based on 18F-FDG and 18F-OC for neuroendocrine neoplasms","volume":"2022","author":"Hou","year":"2022","journal-title":"Mol Imaging"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s12149-016-1087-6","article-title":"FDG-PET characteristics of H\u00fcrthle cell and follicular adenomas","volume":"30","author":"Pathak","year":"2016","journal-title":"Ann Nucl Med"},{"key":"B23","article-title":"Diagnostic accuracy and prognostic value of 18F-FDG PET in H\u00fcrthle cell thyroid cancer patients","volume":"47","author":"Pryma","year":"2006","journal-title":"J Nucl Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)61132-7","article-title":"Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on H\u00fcrthle cell tumors","volume":"160","author":"M\u00e1ximo","year":"2002","journal-title":"Am J Pathol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0703056104","article-title":"Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors","volume":"104","author":"Gasparre","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198312153092406","article-title":"Somatostatin","volume":"309","author":"Reichlin","year":"1983","journal-title":"N Engl J Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2020.01.011","article-title":"Somatostatin receptor expression and mTOR pathway activation in glioneuronal tumours of childhood","volume":"76","author":"Ehrstedt","year":"2020","journal-title":"Seizure"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2020.105865","article-title":"Somatostatin receptor profile in pituitary thyrotroph adenomas","volume":"195","author":"Thodou","year":"2020","journal-title":"Clin Neurol Neurosurg"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab258","article-title":"Utility of 18F-alF-NOTA-octreotide PET\/CT in the localization of tumor-induced osteomalacia","volume":"106","author":"Long","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-011-0250-x","article-title":"Optimized labeling of NOTA-conjugated octreotide with F-18","volume":"33","author":"Laverman","year":"2012","journal-title":"Tumour Biol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2023.100332","article-title":"Somatostatin receptor type 2 and thyroid-stimulating hormone receptor expression in oncocytic thyroid neoplasms: implications for prognosis and treatment","volume":"36","author":"Gillis","year":"2023","journal-title":"Mod Pathol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000002873","article-title":"H\u00fcrthle cell thyroid adenoma showing avid uptake on 18F-PSMA-1007 PET\/CT","volume":"45","author":"Tang","year":"2020","journal-title":"Clin Nucl Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.2967\/jnmt.114.145433","article-title":"Oncocytic adenoma of thyroid incidentally detected by 18F-fluorocholine PET\/CT","volume":"43","author":"Aziz","year":"2015","journal-title":"J Nucl Med Technol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s11307-021-01628-7","article-title":"Biodistribution of 18F-alF-NOTA-octreotide in different organs and characterization of uptake in neuroendocrine neoplasms","volume":"23","author":"Hou","year":"2021","journal-title":"Mol Imaging Biol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1612851\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T04:11:06Z","timestamp":1756440666000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1612851\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":34,"alternative-id":["10.3389\/fendo.2025.1612851"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1612851","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]},"article-number":"1612851"}}